Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer

Fig. 1

a The changes in size of unresected GGO lesions during the medication. b The information of drug use was recorded in 22 patients with reduction in size of lesions. c The distribution of EGFR mutations in 29 patients with multiple lesions resected. The upper and lower tables show the types of mutation in patients who underwent one and two operations, respectively. The Lesion A, B and C represent different lesions resected in one same operation, while the Lesion 1 and 2 represent the lesions resected in the first and second operation. Meanwhile, for patients who underwent two operations, different colors were filled in the same table cell when multiple lesions were removed in one operation. d The second surgery rate of unresected lesions in the EGFR-TKIs treatment group and control group

Back to article page